FindTrial
Sign In

Survey on the Intake of Oral Nutritional Supplements in Cancer Patients

Survey on the Intake of Oral Nutritional Supplements in Cancer Patients - Survey on the Intake of Oral Nutritional Supplements in Cancer Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000056804
Enrollment
100
Registered
2025-02-01
Start date
2025-02-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Patients

Interventions

None listed

Sponsors

Nestle Japan Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Persons diagnosed with cancer 2. Aged 20 years or older 3. Those who have consumed Product A 4. Those who fully understand the research content and have provided voluntary consent to participate in this study 5. Capable of independently answering the survey

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
1. Background of the Study Participants (Age, Gender, Type of Cancer, Cancer Treatment, Presence of Appetite or Taste Disorders, and Oral Mucositis) 2. Feedback on Product A (Taste, Texture, Ease of Consumption, Intent to Continue Intake, and Willingness to Recommend to Others)—

Countries

Japan

Contacts

Public ContactHiroki Takano

Nestle Japan Ltd Nestle Health Science Company

Hiroki.Takano@jp.nestle.com070-2448-5234

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026